FDA Warns of Fake Avastin

WASHINGTON (MedPage Today) — The FDA has alerted healthcare professionals that foreign sellers are marketing an inactive, counterfeit version of bevacizumab, approved in the U.S. under the brand name Avastin.

Post a Comment

Comments are closed.